Bender Robert & Associates’s Evolus EOLS Stock Holding History

Bender Robert & Associates’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$103K	Buy	+25,070	New	+$121K	0.02%	45
2025 Q4	–	Sell	-25,070	Closed	-$154K	–	42
2025 Q3	$154K	Hold	25,070	–	–	0.03%	46
2025 Q2	$231K	Buy	+25,070	New	+$257K	0.05%	40
2025 Q1	–	Sell	-25,070	Closed	-$277K	–	43
2024 Q4	$277K	Buy	+25,070	New	+$353K	0.07%	40
2024 Q1	–	Sell	-25,070	Closed	-$264K	–	46
2023 Q4	$264K	Hold	25,070	–	–	0.07%	42
2023 Q3	$229K	Hold	25,070	–	–	0.07%	44
2023 Q2	$182K	Hold	25,070	–	–	0.05%	47
2023 Q1	$212K	Buy	+25,070	New	+$227K	0.07%	51
2022 Q4	–	Sell	-25,070	Closed	-$202K	–	50
2022 Q3	$202K	Hold	25,070	–	–	0.08%	48
2022 Q2	$291K	Buy	+25,070	New	+$296K	0.11%	44
2021 Q2	–	Sell	-25,000	Closed	-$325K	–	48
2021 Q1	$325K	Buy	+25,000	New	+$230K	0.1%	48

Other funds holding EOLS

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bender Robert & Associates's EOLS Position: Q1 2026 in Review

Bender Robert & Associates opened a new position in Evolus (EOLS) in Q1 2026: 25,070 shares worth $103K. The stake represents 0.02% of the portfolio and ranks #45 among its holdings. This is a return to the name: Bender Robert & Associates previously reported a position in EOLS as recently as Q3 2025.

Bender Robert & Associates first reported a position in EOLS in Q1 2021 and has held it in 11 quarters since. The position peaked at $325K in Q1 2021. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

Bender Robert & Associates held 25,070 shares of Evolus worth $103K as of Q1 2026.
Evolus was a new Bender Robert & Associates position in Q1 2026.
Evolus made up 0.02% of Bender Robert & Associates's portfolio in Q1 2026, its #45 holding.
Bender Robert & Associates first reported a position in Evolus in Q1 2021 and has held it in 11 quarters since.
Bender Robert & Associates's Evolus position peaked at $325K in Q1 2021.
147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Bender Robert & Associates's 13F filing for Q1 2026, filed 23 Apr 2026.